Evidence map›Paper›PMID 30160165›Full record

ArticleAntioxidants & redox signaling2018

Glutathione Stimulates Vitamin D Regulatory and Glucose-Metabolism Genes, Lowers Oxidative Stress and Inflammation, and Increases 25-Hydroxy-Vitamin D Levels in Blood: A Novel Approach to Treat 25-Hydroxyvitamin D Deficiency.

Sushil K Jain, Rajesh Parsanathan, Arunkumar E Achari, Preeti Kanikarla-Marie, Joseph A Bocchini

Open access · hybridAbstract read
In one paragraph

Article in Antioxidants & redox signaling, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed
8.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 96 citations in OpenAlex.

  1. Trial
  2. Article
  3. A study of 25-(OH)DExperimental and therapeutic medicine · 2026
    Article
  4. Potential Value of a Combination ofPharmaceuticals (Basel, Switzerland) · 2026
    Article
  5. Article
  6. Article
  7. EarlyFrontiers in immunology · 2025
    Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Vitamin D and COVID-19: where are we now?Postgraduate medicine · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Sushil K JainDepartment of Pediatrics, Louisiana State University Health Sciences Center , Shreveport, Louisiana.
Rajesh ParsanathanDepartment of Pediatrics, Louisiana State University Health Sciences Center , Shreveport, Louisiana.
Arunkumar E AchariDepartment of Pediatrics, Louisiana State University Health Sciences Center , Shreveport, Louisiana.
Preeti Kanikarla-MarieDepartment of Pediatrics, Louisiana State University Health Sciences Center , Shreveport, Louisiana.
Joseph A BocchiniDepartment of Pediatrics, Louisiana State University Health Sciences Center , Shreveport, Louisiana.
Louisiana State University Health Sciences Center New Orleans · US

Funding

L-cysteine, PIP3 and Insulin Signaling in DiabetesR01AT007442 · NCCIH · LOUISIANA STATE UNIV HSC SHREVEPORT · PI JAIN, SUSHIL K · 2014 to 2015
$643k
NCCIH NIH HHS R01 AT007442
6 · The paper itself

Abstract

aims25-Hydroxyvitamin D [25(OH)VD] deficiency/inadequacy is a major public health issue affecting more than 1 billion people worldwide. A convincing association exists between low levels of circulating 25(OH)VD and the poor health outcomes associated with chronic diseases. However, high supraphysiological doses of VD are needed to achieve the required 25(OH)VD levels in the blood, because many subjects respond poorly to supplementation.

resultsThis study reports a link between 25(OH)VD deficiency and a reduction in glutathione (GSH) in obese adolescents. The improvement in GSH status that results from cosupplementation with VD and l-cysteine (LC; a GSH precursor) significantly reduced oxidative stress in a mouse model of 25(OH)VD deficiency. It also positively upregulated VD regulatory genes (VDBP/VD-25-hydroxylase/VDR) in the liver and glucose metabolism genes (PGC-1α/VDR/GLUT-4) in muscle, boosted 25(OH)VD, and reduced inflammation and insulin resistance (IR) levels in the blood compared with supplementation with VD alone. In vitro GSH deficiency caused increased oxidative stress and downregulation of VDBP/VD-25-hydroxylase/VDR and upregulation of CYP24a1 in hepatocytes and downregulation of PGC-1α/VDR/GLUT-4 in myotubes. This study demonstrates that improvement in the GSH status exerts beneficial effects on the blood levels of 25(OH)VD, as well as on the inflammation and IR in a VD-deficient mouse model. Thus, the VD supplements widely consumed by the public are unlikely to be successful unless the GSH status is also corrected. INNOVATION: These studies demonstrate a previously undiscovered mechanism by which GSH status positively upregulates the bioavailability of 25(OH)VD.

conclusionSupplementation with a combination of VD and LC or GSH precursor, rather than supplementation with VD alone, is beneficial and helps achieve more successful VD supplementation. Antioxid. Redox Signal. 00, 000-000.

Indexed as

AdolescentAnimalsCells, CulturedDisease Models, AnimalFemaleGlucoseGlutathioneHumansInflammationMaleMiceMice, Inbred C57BLOxidative StressVitamin DVitamin D DeficiencyGlucoseGlutathioneVitamin D25-hydroxyvitamin Dglutathioneinflammationinsulin resistancevitamin D binding proteinvitamin D receptor

Identifiers

PMID30160165
PMCPMC6208166
OpenAlexW2904810024

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.